Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenabasum in Cystic Fibrosis
DRKS00015967Phase 3Recruiting
- Sponsor
- Corbus Pharmaceuticals Holdings, Inc.
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 25
01
Overview
Phase 3, randomised, double-blind trial of lenabasum in cystic fibrosis (CF) (3 arms), sponsored by Corbus Pharmaceuticals Holdings, Inc. Started Dec 2018; status: recruiting.
02
Drugs
lenabasum
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on DRKS00015967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00015967.